Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Management of bleeding problems with hormone replacement therapy

Tim Hillard1

  • 1Department of Obstetrics and Gynaecology, Poole General Hospital, Dorset, UK. thillard@poole.tr.swest.nhs.uk

The Journal of Family Planning and Reproductive Health Care
|November 7, 2002
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Women's Treatment Preferences for Moderate to Severe Vasomotor Symptoms Associated with Menopause: Insights from the WARMER Study.

The patient·2026
Same author

Informal invitation from Climacteric: The Perimenopause - Special Issue Invited Abstracts.

Climacteric : the journal of the International Menopause Society·2026
Same author

Modern Management of the Menopause: Are We Measuring What Matters?

BJOG : an international journal of obstetrics and gynaecology·2026
Same author

Managing with evidence: the International Menopause Society (IMS) recommendations.

Climacteric : the journal of the International Menopause Society·2025
Same author

Factors Associated With Non-Vasomotor Menopause Symptoms Experienced by 7285 Women: A UK-Wide National Survey.

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

Feasibility of developing a new tool for assessing vaginal health in women with Genitourinary Syndrome of Menopause; The VAN study.

Post reproductive health·2025